ELOX
Eloxx Pharmaceuticals, Inc. Common StockPINKHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$46.46M
P/E Ratio
—
EPS
$-1.32
Beta
-168027.67
52W High
$15.86
52W Low
$0.00
50-Day MA
$12.04
200-Day MA
$12.04
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
15.77
PEG Ratio
1.85
About Eloxx Pharmaceuticals, Inc. Common Stock
Eloxx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, is focused on developing ribonucleic acid modulator drug candidates for the treatment of rare and ultra-rare premature stop codon diseases. The company is headquartered in Waltham, Massachusetts.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-6.40M |
| Operating Margin | 0.00% |
| Return on Equity | -615.00% |
| Return on Assets | -97.60% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $-16.45 |
| Price-to-Book | 62.37 |
| Price-to-Sales (TTM) | 103.57 |
| EV/Revenue | 97.45 |
| EV/EBITDA | 0.10 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $3.44M |
| Float | 532,090 |
| % Insiders | 0.93% |
| % Institutions | 0.82% |
Historical Volatility
HV 10-Day
—
HV 20-Day
—
HV 30-Day
—
HV 60-Day
—
HV Rank
—
More HEALTHCARE Stocks
Data last updated: 6/13/2026